ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 84 filers reported holding ALBIREO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $763 | -99.9% | 35,322 | +0.9% | 0.02% | +22.2% |
| Q3 2022 | $678,000 | +224.4% | 35,000 | +290.6% | 0.02% | +260.0% |
| Q4 2021 | $209,000 | -26.4% | 8,961 | -1.7% | 0.01% | -16.7% |
| Q3 2021 | $284,000 | -42.3% | 9,113 | -34.8% | 0.01% | -45.5% |
| Q2 2021 | $492,000 | +3.6% | 13,980 | +3.7% | 0.01% | +10.0% |
| Q1 2021 | $475,000 | -9.7% | 13,481 | -3.9% | 0.01% | 0.0% |
| Q4 2020 | $526,000 | +5.0% | 14,032 | -6.5% | 0.01% | -23.1% |
| Q3 2020 | $501,000 | -52.7% | 15,000 | -62.5% | 0.01% | -56.7% |
| Q2 2020 | $1,060,000 | +49.5% | 40,000 | -7.7% | 0.03% | +7.1% |
| Q1 2020 | $709,000 | -24.7% | 43,337 | +17.1% | 0.03% | +86.7% |
| Q4 2019 | $941,000 | +34.4% | 37,000 | +5.7% | 0.02% | +7.1% |
| Q3 2019 | $700,000 | -37.9% | 35,000 | 0.0% | 0.01% | -53.3% |
| Q2 2019 | $1,128,000 | -41.6% | 35,000 | -41.7% | 0.03% | -37.5% |
| Q1 2019 | $1,933,000 | +31.3% | 60,000 | 0.0% | 0.05% | -21.3% |
| Q4 2018 | $1,472,000 | -18.7% | 60,000 | +9.2% | 0.06% | +27.1% |
| Q3 2018 | $1,811,000 | -7.3% | 54,933 | -0.1% | 0.05% | +2.1% |
| Q2 2018 | $1,953,000 | +71.3% | 55,000 | +57.1% | 0.05% | +30.6% |
| Q1 2018 | $1,140,000 | – | 35,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |